Stingeni, Luca, Roberto Ravasio, Chiara Palladino, Sara Di Fino, Anna Levi, Gianluca Ronci, and Paolo Gisondi. 2025. “Cost Per Responder of Upadacitinib 30 Mg and Dupilumab 300 Mg in Patients With Moderate-to-Severe Atopic Dermatitis in Italy”. Global and Regional Health Technology Assessment 12 (1):70-79. https://doi.org/10.33393/grhta.2025.3458.